MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Castle Biosciences ROCE Ratio 2011-2026 | CSTL
Annual ROCE Ratio Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | -17.37 | -18.25 | -9.73 | -1.56 | 7.02 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.02 | -18.25 | -6.33 |
Quarterly ROCE Ratio Castle Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.58 | -4.97 | -2.86 | 0.97 | -1.52 | -5.17 | -11.94 | -16.27 | -21.5 | -24.24 | -19.59 | -12.35 | -15.22 | -12.85 | -14.03 | -6.01 | -6.95 | -5.02 | -3.06 | -0.84 | 4.36 | 10.5 | 11.37 | 5.54 | 10.58 | 10.42 | 14.42 | 9.76 | 9.76 | 4.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.42 | -24.24 | -3.32 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
29.32 | $ 9.33 | 0.76 % | $ 622 M |  USA |
 |
DexCom
DXCM
|
33.2 | $ 63.66 | -3.68 % | $ 24.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.54 | -5.13 % | $ 470 M | USA |
|
Biodesix
BDSX
|
-41.6 | $ 13.97 | -4.32 % | $ 1.81 B | USA |
 |
DarioHealth Corp.
DRIO
|
-36.38 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 103.93 | 0.82 % | $ 8.57 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
IQVIA Holdings
IQV
|
33.55 | $ 165.44 | -2.34 % | $ 28.4 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
61.76 | $ 567.77 | -0.96 % | $ 45.7 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 119.22 | -4.16 % | $ 19 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 75.32 | -1.36 % | $ 5.08 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 457.07 | -2.04 % | $ 13.2 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 238.68 | -2.47 % | $ 25.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.42 | -4.44 % | $ 409 M | USA |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
-76.66 | $ 191.42 | -2.41 % | $ 18.8 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.08 | -1.62 % | $ 382 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
OPKO Health
OPK
|
-7.58 | $ 1.13 | -3.85 % | $ 784 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 157.42 | -4.67 % | $ 7.8 B | USA |
 |
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.27 | -5.93 % | $ 381 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 4.8 | 4.58 % | $ 2.58 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 6.66 | -9.02 % | $ 395 M | USA |
 |
PerkinElmer
PKI
|
4.92 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
-365.72 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
5.69 | $ 57.34 | -3.49 % | $ 4.31 B | USA |
 |
Sotera Health Company
SHC
|
70.91 | $ 13.26 | -2.07 % | $ 3.77 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 30.09 | -5.48 % | $ 1.53 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 478.97 | -2.06 % | $ 181 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.62 | 1.06 % | $ 61.9 M | Irlanda |